The journey in diagnosis and treatment, from pituitary adenoma to aggressive pituitary tumors

[1]  M. Fleseriu,et al.  Updates in the Medical Treatment of Pituitary Adenomas , 2019, Hormone and Metabolic Research.

[2]  F. Casanueva,et al.  A tale of pituitary adenomas: to NET or not to NET , 2019, Pituitary.

[3]  M. Fleseriu,et al.  Physicians’ awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a “Pituitary Society” survey , 2018, Pituitary.

[4]  S. McCartney,et al.  Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study , 2018, Pituitary.

[5]  O. Dekkers,et al.  Aggressive pituitary tumours and carcinomas: two sides of the same coin? , 2018, European journal of endocrinology.

[6]  O. Dekkers,et al.  Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. , 2018, European journal of endocrinology.

[7]  O. Dekkers,et al.  European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. , 2018, European journal of endocrinology.

[8]  C. Yedinak,et al.  Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review , 2018, Pituitary.

[9]  P. Chanson,et al.  Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement , 2017, Pituitary.

[10]  D. Donoho,et al.  Management of aggressive growth hormone secreting pituitary adenomas , 2017, Pituitary.

[11]  J. Lupski,et al.  Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study , 2016, Acta neuropathologica communications.

[12]  A. Tirosh,et al.  Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas , 2016, Pituitary.

[13]  S. Ellard,et al.  Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers , 2015, The Journal of clinical endocrinology and metabolism.

[14]  Antonio Di Ieva,et al.  Aggressive pituitary adenomas—diagnosis and emerging treatments , 2014, Nature Reviews Endocrinology.

[15]  S. Melmed.  Pathogenesis of pituitary tumors , 2011, Nature Reviews Endocrinology.

[16]  M. Korbonits,et al.  Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma , 2010, Expert review of endocrinology & metabolism.